Broderick Brian C Purchases 4,280 Shares of Xylem Inc. $XYL

Broderick Brian C lifted its position in Xylem Inc. (NYSE:XYL) by 6.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,481 shares of the industrial products company’s stock after purchasing an additional 4,280 shares during the quarter. Xylem accounts for 1.6% of Broderick Brian C’s portfolio, making the stock its 21st largest position. Broderick Brian C’s holdings in Xylem were worth $8,900,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Orion Porfolio Solutions LLC increased its holdings in Xylem by 1.0% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after buying an additional 74 shares during the period. Quest Investment Management LLC lifted its holdings in shares of Xylem by 1.0% during the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after acquiring an additional 77 shares during the period. SWS Partners boosted its position in shares of Xylem by 1.1% during the 4th quarter. SWS Partners now owns 7,402 shares of the industrial products company’s stock valued at $1,008,000 after acquiring an additional 82 shares in the last quarter. Notis McConarty Edward boosted its position in shares of Xylem by 0.3% during the 4th quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock valued at $4,314,000 after acquiring an additional 86 shares in the last quarter. Finally, Moneco Advisors LLC increased its stake in Xylem by 4.6% in the fourth quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock valued at $279,000 after acquiring an additional 90 shares during the period. 87.96% of the stock is owned by institutional investors.

Xylem Stock Performance

Shares of NYSE:XYL opened at $122.96 on Monday. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The firm has a market cap of $29.23 billion, a PE ratio of 30.59, a price-to-earnings-growth ratio of 1.75 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The business has a fifty day moving average of $113.23 and a 200-day moving average of $123.37.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same quarter in the prior year, the company earned $1.03 EPS. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, equities research analysts predict that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Analyst Ratings Changes

Several research analysts recently issued reports on XYL shares. JPMorgan Chase & Co. dropped their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, April 16th. Oppenheimer decreased their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Stifel Nicolaus lowered their price objective on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and raised their target price for the stock from $130.00 to $140.00 in a research report on Thursday, June 25th. Finally, Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus price target of $153.31.

Insider Buying and Selling

In other Xylem news, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.32% of the stock is currently owned by corporate insiders.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.